Search

Search Constraints

You searched for: Author/Creator Verzeroli, C.

Search Results

1. Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study. Issue 164 (April 2018)

2. Hypercoagulable State as innovative tool for risk assessment and early cancer diagnosis: Data from HYPERCAN Prospective Study. Issue 164 (April 2018)

3. OC-06: Identification of predictive hemostatic biomarkers for cancer diagnosis: results from the HYPERCAN study. Issue 213 (May 2022)

4. PO-04: Thrombin generation and D-dimer significantly predict for early disease progression and mortality in patients with gastrointestinal cancer. Issue 213 (May 2022)

5. OC-1a: A prospective study of hemostatic biomarkers to predict early recurrence in high-risk breast cancer women undergoing post-surgical adjuvant systemic therapy. Issue 151 (March 2017)

6. Thrombin generation predicts for early recurrence in breast cancer patients undergoing post-surgical adjuvant therapy: results from the HYPERCAN study. Issue 164 (April 2018)

7. PO-83 Assessment model for thrombotic risk in a prospective cohort of newly diagnosed metastatic cancer outpatient candidates for chemotherapy. Issue 200 (April 2021)

8. PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN). Issue 140 (April 2016)